カテゴリ： GlobalData, アメリカ, 企業調査

DaVita Inc (DVA)-医療機器分野：企業M&A・提携分析

◆英語タイトル：DaVita Inc (DVA) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011115
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月21日
◆ページ数：75
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). It also focuses on providing integrated health care delivery and management services. It also offers ancillary services, including pharmacy services such as DaVita Rx; infusion therapy services, disease management services; vascular access services; ESRD clinical research programs and physician services. The company operates through a network of outpatient dialysis centers in hospitals and related laboratory services. DaVita Medical Group manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, Florida, New Mexico and Colorado. DaVita is headquartered in Colorado, the US.

DaVita Inc (DVA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
DaVita Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
DaVita Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
DaVita Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
DaVita Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
DaVita Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
DaVita Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
DaVita HealthCare To Acquire Dialysis Products From B. Braun Medical 11
Venture Financing 12
CVRx Raises US$42 Million In Series F Financing 12
Partnerships 14
DaVita Enters Into Agreement With Myriad Genetics For Protein Biomarker Discovery 14
Debt Offering 15
DaVita HealthCare Prices Public Offering of 5% Notes Due 2025 for USD1.5 Billion 15
DaVita HealthCare Raises USD1.75 Billion in Public Offering of 5.125% Notes Due 2024 17
Acquisition 19
DaVita Acquires Centrum Dializa 19
DaVita Healthcare Partners to Acquire Renal Ventures for USD415 Million 20
Berkshire Hathaway Acquires Minority Stake In DaVita HealthCare Partners 21
DaVita Inc – Key Competitors 22
DaVita Inc – Key Employees 23
DaVita Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 27
Recent Developments 28
Financial Announcements 28
Nov 07, 2017: DaVita 3rd Quarter 2017 Results 28
Aug 01, 2017: DaVita Reports 2nd Quarter 2017 Results 30
May 02, 2017: DaVita Reports 1st Quarter 2017 Results 32
Feb 16, 2017: DaVita 4th Quarter 2016 Results 34
Nov 02, 2016: DaVita 3rd Quarter 2016 Results 36
Aug 08, 2016: DaVita HealthCare Partners 2nd Quarter 2016 Results 38
May 04, 2016: DaVita HealthCare Partners 1st Quarter 2016 Results 40
Feb 11, 2016: DaVita HealthCare Partners 4th Quarter 2015 Results 43
Corporate Communications 45
Nov 02, 2017: DaVita Boosts Efforts to Educate During National Diabetes Month 45
Jun 29, 2017: DaVita Medical Group Recognized for Excellence in Coordinated Care 46
May 24, 2017: DaVita Kidney Care Welcomes Eric Severson as Chief People Officer 47
May 18, 2017: Dr. George R. Aronoff Joins DaVita Kidney Care Physician Leadership Team 48
Apr 10, 2017: DaVita Names New President of International 49
Mar 08, 2017: DaVita Kidney Care Welcomes Dr. Francesca Tentori to Physician Leadership Team 50
Feb 28, 2017: Dr. Adam Weinstein Joins DaVita Kidney Care Physician Leadership Team 51
Feb 23, 2017: DaVita Appoints Chief Medical Officer for Integrated Kidney Care 52
Jan 05, 2017: DaVita Announces Joel Ackerman to be CFO 53
Jan 05, 2017: DaVita Appoints Pascal Desroches to Board of Directors 54
Dec 21, 2016: “DaVita Way of Giving” Donates Record-breaking $2.2 Million to Local Charities 55
Sep 14, 2016: DaVita Names New President for Florida Medical Group Operations 56
Aug 30, 2016: The Everett Clinic Announces Leadership Transitions 57
Aug 30, 2016: DaVita Kidney Care Welcomes Dr. Bryan Becker to Physician Leadership Team 58
Aug 23, 2016: DaVita Kidney Care Welcomes Dr. Jeff Giullian to Physician Leadership Team 59
Jul 13, 2016: DaVita Appoints Phyllis R. Yale to Board of Directors 60
Jul 01, 2016: DaVita HealthCare Partners Names Oraida Roman President of Colorado Springs Health Partners 61
Jun 13, 2016: Amar Desai, M.D., Returns to DaVita HealthCare Partners 62
May 10, 2016: DaVita Appoints President for Kidney Care Business in Asia Pacific 63
Jan 21, 2016: DaVita HealthCare Partners Announces Jim Rechtin Named President of HealthCare Partners’ California Market 64
Jan 21, 2016: Jim Rechtin Named President of HealthCare Partners’ California Market 65
Jan 12, 2016: Chris Miller Joins Paladina Health as Chief Executive Officer 66
Legal and Regulatory 67
Dec 14, 2017: DaVita Kidney Care Issues Statement about DaVita Rx Settlement 67
Aug 17, 2016: DaVita Hospital Services Receives Re-Accreditation from The Joint Commission 68
Mar 09, 2016: DaVita World Headquarters Awarded LEED Platinum Certification by U.S. Green Building Council 69
Government and Public Interest 70
Jul 18, 2016: DaVita Joins Patients and Providers to Urge Congress to Pass Bipartisan Dialysis PATIENT Demonstration Act 70
Other Significant Developments 71
Dec 14, 2017: DaVita Addresses Physician Fatigue with Investment in DaVita Physician Solutions 71
Oct 31, 2017: DaVita: Integrated Care Improves Dialysis Patient Clinical Outcomes 72
Jan 09, 2017: DaVita Enters Into New Sourcing and Supply Agreement with Amgen and Initiates 2017 Kidney Care Guidance 73
Mar 23, 2016: DaVita Kidney Care Revamps Customized Online Experience for Those Affected by Kidney Disease 74
Appendix 75
Methodology 75
About GlobalData 75
Contact Us 75
Disclaimer 75

List of Tables
DaVita Inc, Medical Equipment, Key Facts, 2016 2
DaVita Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
DaVita Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
DaVita Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
DaVita Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
DaVita Inc, Deals By Market, 2011 to YTD 2017 9
DaVita Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
DaVita HealthCare To Acquire Dialysis Products From B. Braun Medical 11
CVRx Raises US$42 Million In Series F Financing 12
DaVita Enters Into Agreement With Myriad Genetics For Protein Biomarker Discovery 14
DaVita HealthCare Prices Public Offering of 5% Notes Due 2025 for USD1.5 Billion 15
DaVita HealthCare Raises USD1.75 Billion in Public Offering of 5.125% Notes Due 2024 17
DaVita Acquires Centrum Dializa 19
DaVita Healthcare Partners to Acquire Renal Ventures for USD415 Million 20
Berkshire Hathaway Acquires Minority Stake In DaVita HealthCare Partners 21
DaVita Inc, Key Competitors 22
DaVita Inc, Key Employees 23
DaVita Inc, Other Locations 25
DaVita Inc, Subsidiaries 26
DaVita Inc, Joint Venture 27

★海外企業調査レポート[DaVita Inc (DVA)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • NG Biotech：企業の製品パイプライン分析2018
    Summary NG Biotech is a biotech company that develops and manufactures novel in vitro diagnostic tools for therapy monitoring. The company’s products include whole blood pregnancy tests, M-health malaria tests, NG Test readers, antibiotic resistance tests, and OTC tests. It also develops a proprieta …
  • Mtr Corporation Ltd
    Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • XState Resources Ltd (XST)：企業の財務・戦略的SWOT分析
    Summary XState Resources Ltd (XST) is an oil and gas exploration and development company. The company’s business activities include acquisition, exploration, production and development of oil and gas assets. It holds interest in producing gas wells and associated land leases and production and pipel …
  • Nautilus Minerals Inc.：企業のM&A・事業提携・投資動向
    Nautilus Minerals Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nautilus Minerals Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Jeil Pharmaceutical Co Ltd (002620)：企業の財務・戦略的SWOT分析
    Jeil Pharmaceutical Co Ltd (002620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • VolitionRX Ltd (VNRX)：企業の財務・戦略的SWOT分析
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • Pinnacle West Capital Corporation (PNW)：企業の財務・戦略的SWOT分析
    Pinnacle West Capital Corporation (PNW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Verizon Communications Inc (VZ)：企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Mazda Motor Corporation：企業の戦略・SWOT・財務情報
    Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Industrial Bank Co., Ltd.：企業の戦略・SWOT・財務分析
    Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Straco Corporation Limited：戦略・SWOT・企業財務分析
    Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • AptarGroup Inc：企業の戦略・SWOT・財務情報
    AptarGroup Inc - Strategy, SWOT and Corporate Finance Report Summary AptarGroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ARCA biopharma Inc (ABIO)：医療機器：M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Alliance Healthcare Services Inc：医療機器：M&Aディール及び事業提携情報
    Summary Alliance Healthcare Services Inc (Alliance Healthcare Services) is a provider of outsourced services including diagnostic imaging services. It provides a full line of services ranging from systems, technologists to operate the systems, sales and marketing, patient scheduling and pre-authoriz …
  • Kinnov Therapeutics SAS：製薬・医療：M&Aディール及び事業提携情報
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company provides pipeline product such as KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic rec …
  • PT Kalbe Farma Tbk (KLBF)：製薬・医療：M&Aディール及び事業提携情報
    Summary PT Kalbe Farma Tbk (Kalbe) provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. Its product portfolio comprises br …
  • Ternium SA：戦略・SWOT・企業財務分析
    Ternium SA - Strategy, SWOT and Corporate Finance Report Summary Ternium SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Jamnica dd：企業の戦略・SWOT・財務分析
    Jamnica dd - Strategy, SWOT and Corporate Finance Report Summary Jamnica dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Targa Resources Partners LP (NGLS PR A)：石油・ガス：M&Aディール及び事業提携情報
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. It carries out the gathering, compressing, treating, processing and sale of natural gas, and storing, fractionating, treating, transporting and selling natural gas liquids (NGLs) and NGL products. The company …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆